Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce V Taylor

Showing results (101-110 of 212) with videos related to

Pageof 22
Sort By:
Brain and Behavior|April 18, 2017
Variation within <i>MBP</i> gene predicts disease course in multiple sclerosisYuan Zhou, Steve Simpson, Jac C Charlesworth, et al.
Neurology. Genetics|July 12, 2023
Integrating Genetic Structural Variations and Whole-Genome Sequencing Into Clinical NeurologyXin Lin, Yuanhao Yang, Phillip E Melton, et al.
European Journal of Neurology|May 1, 2021
Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal StudyLara Marie Pangan Lo, Bruce V Taylor, Tania Winzenberg, et al.
Brain and Behavior|December 31, 2024
The Health-Related Quality of Life Impact of the COVID-19 Pandemic on People Living with Multiple Sclerosis and the General Population: A Comparative Study Utilizing the EQ-5D-5L with Psychosocial Bolt-OnsGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pharmacoeconomics|December 31, 2024
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Saliva-derived DNA performs well in large-scale, high-density single-nucleotide polymorphism microarray studiesMelanie Bahlo, Jim Stankovich, Patrick Danoy, et al.
Stem Cell Research|October 22, 2021
Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosisAshish Mehta, Peter Lu, Bruce V Taylor, et al.
Frontiers in Neurology|June 26, 2018
Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier OnsetChunrong Tao, Steve Simpson, Bruce V Taylor, et al.
Pharmacoeconomics|August 2, 2024
Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
Health and Quality of Life Outcomes|October 1, 2024
The subjective wellbeing of people living with Multiple Sclerosis in Australia: insights from the Personal Wellbeing IndexGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pageof 22

Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
Brain and Behavior|April 18, 2017
Variation within <i>MBP</i> gene predicts disease course in multiple sclerosisYuan Zhou, Steve Simpson, Jac C Charlesworth, et al.
Neurology. Genetics|July 12, 2023
Integrating Genetic Structural Variations and Whole-Genome Sequencing Into Clinical NeurologyXin Lin, Yuanhao Yang, Phillip E Melton, et al.
European Journal of Neurology|May 1, 2021
Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal StudyLara Marie Pangan Lo, Bruce V Taylor, Tania Winzenberg, et al.
Brain and Behavior|December 31, 2024
The Health-Related Quality of Life Impact of the COVID-19 Pandemic on People Living with Multiple Sclerosis and the General Population: A Comparative Study Utilizing the EQ-5D-5L with Psychosocial Bolt-OnsGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pharmacoeconomics|December 31, 2024
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Saliva-derived DNA performs well in large-scale, high-density single-nucleotide polymorphism microarray studiesMelanie Bahlo, Jim Stankovich, Patrick Danoy, et al.
Stem Cell Research|October 22, 2021
Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosisAshish Mehta, Peter Lu, Bruce V Taylor, et al.
Frontiers in Neurology|June 26, 2018
Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier OnsetChunrong Tao, Steve Simpson, Bruce V Taylor, et al.
Pharmacoeconomics|August 2, 2024
Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
Health and Quality of Life Outcomes|October 1, 2024
The subjective wellbeing of people living with Multiple Sclerosis in Australia: insights from the Personal Wellbeing IndexGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pageof 22